Sunosi Prescribing & Dosing Schedule

Dosage & Administration Drug label Samples Prior authorization Financial assistance Patient education People also ask

Sunosi (solriamfetol)

sunosi 75 MG Oral Tablet

NO BOXED WARNING

Dosage & Administration

* Administer once daily upon awakening. Avoid administration within 9 hours of planned bedtime because of the potential to interfere with sleep.
* Starting dose for patients with narcolepsy: 75 mg once daily.
* Starting dose for patients with OSA: 37.5 mg once daily.
* Dose may be increased at intervals of at least 3 days.
* Maximum dose is 150 mg once daily.
* Renal impairment :
* Moderate impairment: Starting dose is 37.5 mg once daily.
* May increase to 75 mg once daily after at least 7 days.

* Severe impairment: Starting dose and maximum dose is 37.5 mg once daily.
* End stage renal disease (ESRD): Not recommended.

drug label

Sunosi Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

samples

Request Sunosi Samples

Online Sample Form

Learn More

prior authorization

Sunosi Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Letter of Medical Necessity Guide

Letter of Medical Necessity: Excessive Daytime Sleepiness in Obstructive Sleep Apnea

Letter of Medical Necessity: Excessive Daytime Sleepiness in Narcolepsy

financial assistance

Sunosi Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

patient education

Sunosi Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link